Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business & Regulation


Business & Regulation Business Practice

Expect the Unexpected

| Yong Guo

Scientific careers are inherently unpredictable, but there are a number of steps we can take to be prepared.

Business & Regulation Business Practice

Business in Brief

| Maryam Mahdi

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Business & Regulation Business Practice

How to Commercialize an Orphan Drug

| George A. Chressanthis, Animesh Arun

Orphan drugs for rare diseases represent a significant unmet medical need for pharma, but commercialication can be tricky...

Business & Regulation Small Molecules

And for 2020...

| Stephanie Sutton

Nominations are now open for The Medicine Maker 2020 Power List.

Business & Regulation Trends & Forecasts

2023: Prices and Predictions

| Maryam Mahdi

How will the industry shape up over the next five years?

Business & Regulation Standards & Regulation

The IPEC Story: Promoting Ingredients for Success

| With David Schoneker

High quality excipients make all the difference to the drug development process. And yet, for years, excipients were often overlooked by the industry.

Business & Regulation Business Practice

Solutions In... Human Antibodies

| Maryam Mahdi

John McCafferty, CEO of IONTAS, explains how his company’s work in mammalian cells could bring biopharmaceuticals to market faster.

Business & Regulation Standards & Regulation

Cutting Out the Middleman

| Maryam Mahdi

What are the consequences of allowing patients to purchase cell and gene therapies directly from hospitals?

Business & Regulation Trends & Forecasts

Aid Africa

| Stephanie Sutton

Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.

Business & Regulation Business Practice

Business-In-Brief

| Maryam Mahdi

Social responsibility at its finest, AI partnerships, and a crack down on vaccine manufacturing malpractice... What’s new for pharma in business?

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register